-- グレート・ボルダー・リソーシズ(ASX:GBR)は、機関投資家および適格投資家から4,000万豪ドルを調達する確約を取り付けた。これは2段階に分けて行われる株式発行で、1株あたり0.085豪ドルで約4億7,060万株を発行する。これは、過去10日間の出来高加重平均価格から約14%の割引となる。オーストラリア証券取引所への火曜日の提出書類で明らかになった。 提出書類によると、第1段階では1億4,550万株で約1,240万豪ドル、第2段階では3億2,510万株で約2,760万豪ドルを調達する予定で、いずれも株主の承認が必要となる。 提出書類には、調達資金はウェストゴールド・リソーシズ(ASX:WGX)の完全子会社であるアラゴン・リソーシズからピーク・ヒル金プロジェクトを買収するための資金として使用される、と付け加えられている。 同社の株価は火曜日の取引で19%上昇した。
Related Articles
Smartgroup Welcomes Australian Government Decision to Maintain Electric Car Discount for a Year, Shares Reach Two-Year Peak
Smartgroup (ASX:SIQ) welcomes a decision by the Australian government to maintain the electric car discount for another year, according to a Tuesday statement.It noted that the policy provides certainty for the charging industry, supporting further investment in Australia's charging infrastructure and helping build the network needed for broader electric vehicle adoption.Its shares jumped 7% in recent trading, reaching a two-year peak.
Market Chatter: Qantas CEO Becoming 'More Optimistic' on Fuel Supply
Qantas Airways (ASX:QAN) Chief Executive Vanessa Hudson said the company is becoming "more optimistic" on fuel supply, Bloomberg News reported Tuesday.Speaking at the Macquarie Australia Conference, Hudson said the company has fuel commitments up to the middle of June, per the report.Hudson noted that the airline registered strong demand for domestic and international air travel despite high fuel prices.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Sigma Healthcare Says Chemist Warehouse Brand to Enter UK Under Agreement With Pharmacy Group; Shares Rise 4%
Sigma Healthcare (ASX:SIG) said Tuesday signed a memorandum of understanding with Greenlight Healthcare, under which the Chemist Warehouse brand will enter the UK market.The company said in a statement that it will acquire a 75% interest in a number of stores of the employee-owned pharmacy group, with 25% continuing to be held by GreenLight.Sigma will license the Chemist Warehouse brand and intellectual property, and provide retail support, while GreenLight will provide the dispensary and professional services requirements as well as back office support.The first phase of the joint venture will focus on rebranding and developing up to five stores initially, with the first site to be in Hoxton Street, northeast of the city of London. If the first phase proves to be successful, more stores could be developed in the second phase. The parties plan to identify existing GreenLight pharmacies and where appropriate develop or relocate these into Chemist Warehouse stores.Sigma Healthcare's shares rose nearly 4% in recent trading on Tuesday.